{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T22:00:15Z","timestamp":1791237615118,"version":"4.1.0"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,3,14]],"date-time":"2018-03-14T00:00:00Z","timestamp":1520985600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Bildung und Forschung","doi-asserted-by":"publisher","award":["01EC1009A"],"award-info":[{"award-number":["01EC1009A"]}],"id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arthritis Res Ther"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s13075-018-1540-0","type":"journal-article","created":{"date-parts":[[2018,3,14]],"date-time":"2018-03-14T08:22:33Z","timestamp":1521015753000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Hypogalactosylation of immunoglobulin G in rheumatoid arthritis: relationship to HLA-DRB1 shared epitope, anticitrullinated protein antibodies, rheumatoid factor, and correlation with inflammatory activity"],"prefix":"10.1186","volume":"20","author":[{"given":"Christian","family":"Schwedler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"H\u00e4upl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrich","family":"Kalus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V\u00e9ronique","family":"Blanchard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerd-R\u00fcdiger","family":"Burmester","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denis","family":"Poddubnyy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0784-4017","authenticated-orcid":false,"given":"Berthold","family":"Hoppe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,3,14]]},"reference":[{"issue":"9664","key":"1540_CR1","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1016\/S0140-6736(09)60008-8","volume":"373","author":"L Klareskog","year":"2009","unstructured":"Klareskog L, Catrina AI, Paget S. Rheumatoid arthritis. Lancet. 2009;373(9664):659\u201372.","journal-title":"Lancet"},{"issue":"2","key":"1540_CR2","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1038\/ncprheum0050","volume":"1","author":"JS Smolen","year":"2005","unstructured":"Smolen JS, Aletaha D. Challenges of predicting treatment response in patients with rheumatoid arthritis. Nat Clin Pract Rheumatol. 2005;1(2):62\u20133.","journal-title":"Nat Clin Pract Rheumatol"},{"issue":"9509","key":"1540_CR3","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/S0140-6736(06)68154-3","volume":"367","author":"J Vencovsky","year":"2006","unstructured":"Vencovsky J, Huizinga TW. Rheumatoid arthritis: the goal rather than the health-care provider is key. Lancet. 2006;367(9509):450\u20132.","journal-title":"Lancet"},{"issue":"4","key":"1540_CR4","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1002\/art.10167","volume":"46","author":"M Bukhari","year":"2002","unstructured":"Bukhari M, Lunt M, Harrison BJ, Scott DG, Symmons DP, Silman AJ. Rheumatoid factor is the major predictor of increasing severity of radiographic erosions in rheumatoid arthritis: results from the Norfolk Arthritis Register Study, a large inception cohort. Arthritis Rheum. 2002;46(4):906\u201312.","journal-title":"Arthritis Rheum"},{"issue":"11","key":"1540_CR5","doi-asserted-by":"publisher","first-page":"3381","DOI":"10.1002\/art.22206","volume":"54","author":"T Cantaert","year":"2006","unstructured":"Cantaert T, De Rycke L, Bongartz T, Matteson EL, Tak PP, Nicholas AP, Baeten D. Citrullinated proteins in rheumatoid arthritis: crucial...but not sufficient! Arthritis Rheum. 2006;54(11):3381\u20139.","journal-title":"Arthritis Rheum"},{"issue":"10","key":"1540_CR6","doi-asserted-by":"publisher","first-page":"1937","DOI":"10.1084\/jem.20160792","volume":"213","author":"EM Tan","year":"2016","unstructured":"Tan EM, Smolen JS. Historical observations contributing insights on etiopathogenesis of rheumatoid arthritis and role of rheumatoid factor. J Exp Med. 2016;213(10):1937\u201350.","journal-title":"J Exp Med"},{"issue":"2","key":"1540_CR7","doi-asserted-by":"publisher","first-page":"538","DOI":"10.4049\/jimmunol.171.2.538","volume":"171","author":"JA Hill","year":"2003","unstructured":"Hill JA, Southwood S, Sette A, Jevnikar AM, Bell DA, Cairns E. Cutting edge: the conversion of arginine to citrulline allows for a high-affinity peptide interaction with the rheumatoid arthritis-associated HLA-DRB1*0401 MHC class II molecule. J Immunol. 2003;171(2):538\u201341.","journal-title":"J Immunol"},{"issue":"10","key":"1540_CR8","doi-asserted-by":"publisher","first-page":"3085","DOI":"10.1002\/art.20553","volume":"50","author":"L Padyukov","year":"2004","unstructured":"Padyukov L, Silva C, Stolt P, Alfredsson L, Klareskog L. A gene-environment interaction between smoking and shared epitope genes in HLA-DR provides a high risk of seropositive rheumatoid arthritis. Arthritis Rheum. 2004;50(10):3085\u201392.","journal-title":"Arthritis Rheum"},{"issue":"1","key":"1540_CR9","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1002\/art.21575","volume":"54","author":"L Klareskog","year":"2006","unstructured":"Klareskog L, Stolt P, Lundberg K, K\u00e4llberg H, Bengtsson C, Grunewald J, Ronnelid J, Harris HE, Ulfgren AK, Rantap\u00e4\u00e4-Dahlqvist S, et al. A new model for an etiology of rheumatoid arthritis: smoking may trigger HLA-DR (shared epitope)-restricted immune reactions to autoantigens modified by citrullination. Arthritis Rheum. 2006;54(1):38\u201346.","journal-title":"Arthritis Rheum"},{"issue":"5","key":"1540_CR10","doi-asserted-by":"publisher","first-page":"1446","DOI":"10.1002\/art.22597","volume":"56","author":"M Pedersen","year":"2007","unstructured":"Pedersen M, Jacobsen S, Garred P, Madsen HO, Klarlund M, Svejgaard A, Pedersen BV, Wohlfahrt J, Frisch M. Strong combined gene-environment effects in anti-cyclic citrullinated peptide-positive rheumatoid arthritis: a nationwide case-control study in Denmark. Arthritis Rheum. 2007;56(5):1446\u201353.","journal-title":"Arthritis Rheum"},{"issue":"4","key":"1540_CR11","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1002\/art.10514","volume":"47","author":"DL Mattey","year":"2002","unstructured":"Mattey DL, Dawes PT, Clarke S, Fisher J, Brownfield A, Thomson W, Hajeer AH, Ollier WE. Relationship among the HLA-DRB1 shared epitope, smoking, and rheumatoid factor production in rheumatoid arthritis. Arthritis Rheum. 2002;47(4):403\u20137.","journal-title":"Arthritis Rheum"},{"issue":"12","key":"1540_CR12","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1016\/0161-5890(91)90039-M","volume":"28","author":"PM Rudd","year":"1991","unstructured":"Rudd PM, Leatherbarrow RJ, Rademacher TW, Dwek RA. Diversification of the IgG molecule by oligosaccharides. Mol Immunol. 1991;28(12):1369\u201378.","journal-title":"Mol Immunol"},{"issue":"7","key":"1540_CR13","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1016\/j.autrev.2014.02.005","volume":"13","author":"R Goulabchand","year":"2014","unstructured":"Goulabchand R, Vincent T, Batteux F, Eliaou JF, Guilpain P. Impact of autoantibody glycosylation in autoimmune diseases. Autoimmun Rev. 2014;13(7):742\u201350.","journal-title":"Autoimmun Rev"},{"issue":"3","key":"1540_CR14","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1016\/j.bbagen.2007.06.012","volume":"1780","author":"A Kobata","year":"2008","unstructured":"Kobata A. The N-linked sugar chains of human immunoglobulin G: their unique pattern, and their functional roles. Biochim Biophys Acta. 2008;1780(3):472\u20138.","journal-title":"Biochim Biophys Acta"},{"issue":"12\u201313","key":"1540_CR15","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/S0161-5890(00)00105-X","volume":"37","author":"Y Mimura","year":"2000","unstructured":"Mimura Y, Church S, Ghirlando R, Ashton PR, Dong S, Goodall M, Lund J, Jefferis R. The influence of glycosylation on the thermal stability and effector function expression of human IgG1-Fc: properties of a series of truncated glycoforms. Mol Immunol. 2000;37(12\u201313):697\u2013706.","journal-title":"Mol Immunol"},{"issue":"Pt 2","key":"1540_CR16","first-page":"279","volume":"187","author":"RA Dwek","year":"1995","unstructured":"Dwek RA, Lellouch AC, Wormald MR. Glycobiology: \u2018the function of sugar in the IgG molecule\u2019. J Anat. 1995;187(Pt 2):279\u201392.","journal-title":"J Anat"},{"key":"1540_CR17","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1146\/annurev.immunol.25.022106.141702","volume":"25","author":"JN Arnold","year":"2007","unstructured":"Arnold JN, Wormald MR, Sim RB, Rudd PM, Dwek RA. The impact of glycosylation on the biological function and structure of human immunoglobulins. Annu Rev Immunol. 2007;25:21\u201350.","journal-title":"Annu Rev Immunol"},{"issue":"1\u20132","key":"1540_CR18","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.jim.2005.08.009","volume":"306","author":"R Niwa","year":"2005","unstructured":"Niwa R, Natsume A, Uehara A, Wakitani M, Iida S, Uchida K, Satoh M, Shitara K. IgG subclass-independent improvement of antibody-dependent cellular cytotoxicity by fucose removal from Asn297-linked oligosaccharides. J Immunol Methods. 2005;306(1\u20132):151\u201360.","journal-title":"J Immunol Methods"},{"issue":"5","key":"1540_CR19","doi-asserted-by":"publisher","first-page":"3466","DOI":"10.1074\/jbc.M210665200","volume":"278","author":"T Shinkawa","year":"2003","unstructured":"Shinkawa T, Nakamura K, Yamane N, Shoji-Hosaka E, Kanda Y, Sakurada M, Uchida K, Anazawa H, Satoh M, Yamasaki M, et al. The absence of fucose but not the presence of galactose or bisecting N-acetylglucosamine of human IgG1 complex-type oligosaccharides shows the critical role of enhancing antibody-dependent cellular cytotoxicity. J Biol Chem. 2003;278(5):3466\u201373.","journal-title":"J Biol Chem"},{"key":"1540_CR20","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1146\/annurev.immunol.22.012703.104558","volume":"22","author":"TB Geijtenbeek","year":"2004","unstructured":"Geijtenbeek TB, van Vliet SJ, Engering A, \u2019t Hart BA, van Kooyk Y. Self- and nonself-recognition by C-type lectins on dendritic cells. Annu Rev Immunol. 2004;22:33\u201354.","journal-title":"Annu Rev Immunol"},{"issue":"5787","key":"1540_CR21","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1126\/science.1129594","volume":"313","author":"Y Kaneko","year":"2006","unstructured":"Kaneko Y, Nimmerjahn F, Ravetch JV. Anti-inflammatory activity of immunoglobulin G resulting from Fc sialylation. Science. 2006;313(5787):670\u20133.","journal-title":"Science"},{"issue":"3","key":"1540_CR22","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1006\/jmbi.2001.4670","volume":"309","author":"P Sondermann","year":"2001","unstructured":"Sondermann P, Kaiser J, Jacob U. Molecular basis for immune complex recognition: a comparison of Fc-receptor structures. J Mol Biol. 2001;309(3):737\u201349.","journal-title":"J Mol Biol"},{"key":"1540_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jaut.2014.12.002","volume":"57","author":"E Maverakis","year":"2015","unstructured":"Maverakis E, Kim K, Shimoda M, Gershwin ME, Patel F, Wilken R, Raychaudhuri S, Ruhaak LR, Lebrilla CB. Glycans in the immune system and the altered glycan theory of autoimmunity: a critical review. J Autoimmun. 2015;57:1\u201313.","journal-title":"J Autoimmun"},{"issue":"8","key":"1540_CR24","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.1016\/j.bbagen.2015.10.016","volume":"1860","author":"G Lauc","year":"2016","unstructured":"Lauc G, Pezer M, Rudan I, Campbell H. Mechanisms of disease: the human N-glycome. Biochim Biophys Acta. 2016;1860(8):1574\u201382.","journal-title":"Biochim Biophys Acta"},{"issue":"6027","key":"1540_CR25","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1038\/316452a0","volume":"316","author":"RB Parekh","year":"1985","unstructured":"Parekh RB, Dwek RA, Sutton BJ, Fernandes DL, Leung A, Stanworth D, Rademacher TW, Mizuochi T, Taniguchi T, Matsuta K, et al. Association of rheumatoid arthritis and primary osteoarthritis with changes in the glycosylation pattern of total serum IgG. Nature. 1985;316(6027):452\u20137.","journal-title":"Nature"},{"issue":"2","key":"1540_CR26","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/0896-8411(89)90148-0","volume":"2","author":"R Parekh","year":"1989","unstructured":"Parekh R, Isenberg D, Rook G, Roitt I, Dwek R, Rademacher T. A comparative analysis of disease-associated changes in the galactosylation of serum IgG. J Autoimmun. 1989;2(2):101\u201314.","journal-title":"J Autoimmun"},{"issue":"8","key":"1540_CR27","doi-asserted-by":"publisher","first-page":"2239","DOI":"10.1002\/art.27533","volume":"62","author":"A Ercan","year":"2010","unstructured":"Ercan A, Cui J, Chatterton DE, Deane KD, Hazen MM, Brintnell W, O\u2019Donnell CI, Derber LA, Weinblatt ME, Shadick NA, et al. Aberrant IgG galactosylation precedes disease onset, correlates with disease activity, and is prevalent in autoantibodies in rheumatoid arthritis. Arthritis Rheum. 2010;62(8):2239\u201348.","journal-title":"Arthritis Rheum"},{"key":"1540_CR28","doi-asserted-by":"publisher","first-page":"6651","DOI":"10.1038\/ncomms7651","volume":"6","author":"U Harre","year":"2015","unstructured":"Harre U, Lang SC, Pfeifle R, Rombouts Y, Fruhbeisser S, Amara K, Bang H, Lux A, Koeleman CA, Baum W, et al. Glycosylation of immunoglobulin G determines osteoclast differentiation and bone loss. Nat Commun. 2015;6:6651.","journal-title":"Nat Commun"},{"issue":"2","key":"1540_CR29","doi-asserted-by":"publisher","first-page":"R43","DOI":"10.1186\/ar3756","volume":"14","author":"A Ercan","year":"2012","unstructured":"Ercan A, Cui J, Hazen MM, Batliwalla F, Royle L, Rudd PM, Coblyn JS, Shadick N, Weinblatt ME, Gregersen P, et al. Hypogalactosylation of serum N-glycans fails to predict clinical response to methotrexate and TNF inhibition in rheumatoid arthritis. Arthritis Res Ther. 2012;14(2):R43.","journal-title":"Arthritis Res Ther"},{"issue":"5","key":"1540_CR30","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1016\/0896-8411(91)90173-A","volume":"4","author":"GA Rook","year":"1991","unstructured":"Rook GA, Steele J, Brealey R, Whyte A, Isenberg D, Sumar N, Nelson JL, Bodman KB, Young A, Roitt IM, et al. Changes in IgG glycoform levels are associated with remission of arthritis during pregnancy. J Autoimmun. 1991;4(5):779\u201394.","journal-title":"J Autoimmun"},{"issue":"11","key":"1540_CR31","doi-asserted-by":"publisher","first-page":"3029","DOI":"10.1074\/mcp.M114.039537","volume":"13","author":"A Bondt","year":"2014","unstructured":"Bondt A, Rombouts Y, Selman MH, Hensbergen PJ, Reiding KR, Hazes JM, Dolhain RJ, Wuhrer M. Immunoglobulin G (IgG) Fab glycosylation analysis using a new mass spectrometric high-throughput profiling method reveals pregnancy-associated changes. Mol Cell Proteomics. 2014;13(11):3029\u201339.","journal-title":"Mol Cell Proteomics"},{"issue":"8","key":"1540_CR32","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.1136\/ard.2008.089292","volume":"68","author":"K Van Beneden","year":"2009","unstructured":"Van Beneden K, Coppieters K, Laroy W, De Keyser F, Hoffman IE, Van den Bosch F, Vander Cruyssen B, Drennan M, Jacques P, Rottiers P, et al. Reversible changes in serum immunoglobulin galactosylation during the immune response and treatment of inflammatory autoimmune arthritis. Ann Rheum Dis. 2009;68(8):1360\u20135.","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"1540_CR33","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1002\/jcla.20191","volume":"21","author":"A Croce","year":"2007","unstructured":"Croce A, Firuzi O, Altieri F, Eufemi M, Agostino R, Priori R, Bombardieri M, Alessandri C, Valesini G, Saso L. Effect of infliximab on the glycosylation of IgG of patients with rheumatoid arthritis. J Clin Lab Anal. 2007;21(5):303\u201314.","journal-title":"J Clin Lab Anal"},{"issue":"8","key":"1540_CR34","doi-asserted-by":"publisher","first-page":"2423","DOI":"10.1002\/art.20431","volume":"50","author":"MM Nielen","year":"2004","unstructured":"Nielen MM, van Schaardenburg D, Reesink HW, Twisk JW, van de Stadt RJ, van der Horst-Bruinsma IE, de Gast T, Habibuw MR, Vandenbroucke JP, Dijkmans BA. Increased levels of C-reactive protein in serum from blood donors before the onset of rheumatoid arthritis. Arthritis Rheum. 2004;50(8):2423\u20137.","journal-title":"Arthritis Rheum"},{"issue":"5","key":"1540_CR35","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1002\/art.27383","volume":"62","author":"IH Song","year":"2010","unstructured":"Song IH, Heldmann F, Rudwaleit M, Listing J, Appel H, Braun J, Sieper J. Different response to rituximab in tumor necrosis factor blocker-naive patients with active ankylosing spondylitis and in patients in whom tumor necrosis factor blockers have failed: a twenty-four-week clinical trial. Arthritis Rheum. 2010;62(5):1290\u20137.","journal-title":"Arthritis Rheum"},{"issue":"12","key":"1540_CR36","doi-asserted-by":"publisher","first-page":"2327","DOI":"10.3899\/jrheum.120201","volume":"39","author":"D Wendling","year":"2012","unstructured":"Wendling D, Dougados M, Berenbaum F, Brocq O, Schaeverbeke T, Mazieres B, Marcelli C, Leparc JM, Bertin P, Robin M, et al. Rituximab treatment for spondyloarthritis. A nationwide series: data from the AIR registry of the French Society of Rheumatology. J Rheumatol. 2012;39(12):2327\u201331.","journal-title":"J Rheumatol"},{"issue":"3","key":"1540_CR37","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1002\/art.1780310302","volume":"31","author":"FC Arnett","year":"1988","unstructured":"Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, Healey LA, Kaplan SR, Liang MH, Luthra HS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1988;31(3):315\u201324.","journal-title":"Arthritis Rheum"},{"issue":"3","key":"1540_CR38","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1002\/art.24483","volume":"60","author":"M Rudwaleit","year":"2009","unstructured":"Rudwaleit M, Haibel H, Baraliakos X, Listing J, Marker-Hermann E, Zeidler H, Braun J, Sieper J. The early disease stage in axial spondylarthritis: results from the German Spondyloarthritis Inception Cohort. Arthritis Rheum. 2009;60(3):717\u201327.","journal-title":"Arthritis Rheum"},{"issue":"6","key":"1540_CR39","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1136\/ard.2008.091983","volume":"68","author":"B Hoppe","year":"2009","unstructured":"Hoppe B, Haupl T, Egerer K, Gruber R, Kiesewetter H, Salama A, Burmester GR, Dorner T. Influence of peptidylarginine deiminase type 4 genotype and shared epitope on clinical characteristics and autoantibody profile of rheumatoid arthritis. Ann Rheum Dis. 2009;68(6):898\u2013903.","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"1540_CR40","doi-asserted-by":"publisher","first-page":"R34","DOI":"10.1186\/ar1889","volume":"8","author":"B Hoppe","year":"2006","unstructured":"Hoppe B, Haupl T, Gruber R, Kiesewetter H, Burmester GR, Salama A, Dorner T. Detailed analysis of the variability of peptidylarginine deiminase type 4 in German patients with rheumatoid arthritis: a case-control study. Arthritis Res Ther. 2006;8(2):R34.","journal-title":"Arthritis Res Ther"},{"issue":"7","key":"1540_CR41","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1002\/elps.201300414","volume":"35","author":"C Schwedler","year":"2014","unstructured":"Schwedler C, Kaup M, Petzold D, Hoppe B, Braicu EI, Sehouli J, Ehlers M, Berger M, Tauber R, Blanchard V. Sialic acid methylation refines capillary electrophoresis laser-induced fluorescence analyses of immunoglobulin G N-glycans of ovarian cancer patients. Electrophoresis. 2014;35(7):1025\u201331.","journal-title":"Electrophoresis"},{"key":"1540_CR42","first-page":"6","volume":"3","author":"A Andersson","year":"2010","unstructured":"Andersson A, Eden P, Olofsson T, Fioretos T. Gene expression signatures in childhood acute leukemias are largely unique and distinct from those of normal tissues and other malignancies. BMC Med Genet. 2010;3:6.","journal-title":"BMC Med Genet"},{"issue":"16","key":"1540_CR43","doi-asserted-by":"publisher","first-page":"3706","DOI":"10.1182\/blood-2008-10-183632","volume":"113","author":"NS Longo","year":"2009","unstructured":"Longo NS, Lugar PL, Yavuz S, Zhang W, Krijger PH, Russ DE, Jima DD, Dave SS, Grammer AC, Lipsky PE. Analysis of somatic hypermutation in X-linked hyper-IgM syndrome shows specific deficiencies in mutational targeting. Blood. 2009;113(16):3706\u201315.","journal-title":"Blood"},{"issue":"8","key":"1540_CR44","doi-asserted-by":"publisher","first-page":"1682","DOI":"10.1002\/1529-0131(199908)42:8<1682::AID-ANR17>3.0.CO;2-X","volume":"42","author":"M Watson","year":"1999","unstructured":"Watson M, Rudd PM, Bland M, Dwek RA, Axford JS. Sugar printing rheumatic diseases: a potential method for disease differentiation using immunoglobulin G oligosaccharides. Arthritis Rheum. 1999;42(8):1682\u201390.","journal-title":"Arthritis Rheum"},{"issue":"11","key":"1540_CR45","doi-asserted-by":"publisher","first-page":"3433","DOI":"10.1002\/art.22171","volume":"54","author":"LA Omtvedt","year":"2006","unstructured":"Omtvedt LA, Royle L, Husby G, Sletten K, Radcliffe CM, Harvey DJ, Dwek RA, Rudd PM. Glycan analysis of monoclonal antibodies secreted in deposition disorders indicates that subsets of plasma cells differentially process IgG glycans. Arthritis Rheum. 2006;54(11):3433\u201340.","journal-title":"Arthritis Rheum"},{"key":"1540_CR46","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1007\/0-387-25515-X_23","volume":"564","author":"A Alavi","year":"2005","unstructured":"Alavi A, Pool AJ, Axford JS. New insights into rheumatoid arthritis associated glycosylation changes. Adv Exp Med Biol. 2005;564:129\u201338.","journal-title":"Adv Exp Med Biol"},{"issue":"8574","key":"1540_CR47","doi-asserted-by":"publisher","first-page":"1486","DOI":"10.1016\/S0140-6736(87)92621-3","volume":"2","author":"JS Axford","year":"1987","unstructured":"Axford JS, Mackenzie L, Lydyard PM, Hay FC, Isenberg DA, Roitt IM. Reduced B-cell galactosyltransferase activity in rheumatoid arthritis. Lancet. 1987;2(8574):1486\u20138.","journal-title":"Lancet"},{"issue":"1","key":"1540_CR48","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1093\/intimm\/2.1.105","volume":"2","author":"K Furukawa","year":"1990","unstructured":"Furukawa K, Matsuta K, Takeuchi F, Kosuge E, Miyamoto T, Kobata A. Kinetic study of a galactosyltransferase in the B cells of patients with rheumatoid arthritis. Int Immunol. 1990;2(1):105\u201312.","journal-title":"Int Immunol"},{"issue":"11","key":"1540_CR49","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1023\/A:1006957711557","volume":"15","author":"J Keusch","year":"1998","unstructured":"Keusch J, Lydyard PM, Berger EG, Delves PJ. B lymphocyte galactosyltransferase protein levels in normal individuals and in patients with rheumatoid arthritis. Glycoconj J. 1998;15(11):1093\u20137.","journal-title":"Glycoconj J"},{"issue":"3","key":"1540_CR50","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1172\/JCI115643","volume":"89","author":"JS Axford","year":"1992","unstructured":"Axford JS, Sumar N, Alavi A, Isenberg DA, Young A, Bodman KB, Roitt IM. Changes in normal glycosylation mechanisms in autoimmune rheumatic disease. J Clin Invest. 1992;89(3):1021\u201331.","journal-title":"J Clin Invest"},{"issue":"3","key":"1540_CR51","doi-asserted-by":"publisher","first-page":"463","DOI":"10.3899\/jrheum.110584","volume":"39","author":"LN Troelsen","year":"2012","unstructured":"Troelsen LN, Jacobsen S, Abrahams JL, Royle L, Rudd PM, Narvestad E, Heegaard NH, Garred P. IgG glycosylation changes and MBL2 polymorphisms: associations with markers of systemic inflammation and joint destruction in rheumatoid arthritis. J Rheumatol. 2012;39(3):463\u20139.","journal-title":"J Rheumatol"},{"issue":"5","key":"1540_CR52","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1007\/s10067-006-0370-7","volume":"26","author":"E Gindzienska-Sieskiewicz","year":"2007","unstructured":"Gindzienska-Sieskiewicz E, Klimiuk PA, Kisiel DG, Gindzienski A, Sierakowski S. The changes in monosaccharide composition of immunoglobulin G in the course of rheumatoid arthritis. Clin Rheumatol. 2007;26(5):685\u201390.","journal-title":"Clin Rheumatol"},{"issue":"2","key":"1540_CR53","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1136\/annrheumdis-2017-211649","volume":"77","author":"B Smiljanovic","year":"2018","unstructured":"Smiljanovic B, Radzikowska A, Kuca-Warnawin E, Kurowska W, Grun JR, Stuhlmuller B, Bonin M, Schulte-Wrede U, Sorensen T, Kyogoku C, et al. Monocyte alterations in rheumatoid arthritis are dominated by preterm release from bone marrow and prominent triggering in the joint. Ann Rheum Dis. 2018;77(2):300\u20138.","journal-title":"Ann Rheum Dis"},{"key":"1540_CR54","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.clim.2016.08.013","volume":"171","author":"B Stuhlmuller","year":"2016","unstructured":"Stuhlmuller B, Mans K, Tandon N, Bonin MO, Smiljanovic B, Sorensen TA, Schendel P, Martus P, Listing J, Detert J, et al. Genomic stratification by expression of HLA-DRB4 alleles identifies differential innate and adaptive immune transcriptional patterns - A strategy to detect predictors of methotrexate response in early rheumatoid arthritis. Clin Immunol. 2016;171:50\u201361.","journal-title":"Clin Immunol"}],"container-title":["Arthritis Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-018-1540-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13075-018-1540-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-018-1540-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,3,13]],"date-time":"2019-03-13T20:07:51Z","timestamp":1552507671000},"score":1,"resource":{"primary":{"URL":"https:\/\/arthritis-research.biomedcentral.com\/articles\/10.1186\/s13075-018-1540-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,14]]},"references-count":54,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["1540"],"URL":"https:\/\/doi.org\/10.1186\/s13075-018-1540-0","relation":{},"ISSN":["1478-6362"],"issn-type":[{"value":"1478-6362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,3,14]]},"assertion":[{"value":"27 October 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 February 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 March 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the ethics committee of Charit\u00e9 \u2013 Universit\u00e4tsmedizin Berlin. Participants were included in the study after they provided informed consent.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors had full access to all data and approved the final version of the manuscript for publication.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"44"}}